Insamo website screenshot

Insamo

Insamo is a biotechnology company building membrane-permeable, orally available cyclic peptides that combine the binding affinity of antibodies with the pharmacology of small molecules for drug discovery. Its platform automates the design, synthesis, and testing of peptides at large scale and applies machine learning across vast chemical spaces to identify therapeutic candidates. Founded in February 2024 with $12M from Playground Global, venBio, and MRL Ventures Fund, the company operates from Berkeley, California and Chippendale, New South Wales, Australia. Insamo currently publishes no public developer or API surface; this profile tracks the company in the API Evangelist network.

Insamo is profiled on the APIs.io network. Tagged areas include Company, Engineered Biology, Biotechnology, Drug Discovery, and Peptides.

🌐 Visit website 📡 Source on GitHub
6.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyEngineered BiologyBiotechnologyDrug DiscoveryPeptidesMachine LearningTherapeutics

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 6.8/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/insamo: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Insamo Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: insamo
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/insamo.png
name: Insamo
description: Insamo is a biotechnology company building membrane-permeable, orally available cyclic peptides that combine
  the binding affinity of antibodies with the pharmacology of small molecules for drug discovery. Its platform automates the
  design, synthesis, and testing of peptides at large scale and applies machine learning across vast chemical spaces to identify
  therapeutic candidates. Founded in February 2024 with $12M from Playground Global, venBio, and MRL Ventures Fund, the company
  operates from Berkeley, California and Chippendale, New South Wales, Australia. Insamo currently publishes no public developer
  or API surface; this profile tracks the company in the API Evangelist network.
url: https://raw.githubusercontent.com/api-evangelist/insamo/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- playground-global
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Engineered Biology
- Biotechnology
- Drug Discovery
- Peptides
- Machine Learning
- Therapeutics
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/insamo-domain-security.yml
- type: Website
  url: https://insamo.com/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence